Create accountLogin

Recent searches

No recent searches

Search options

Only available when logged in.
med-mastodon.com is one of the many independent Mastodon servers you can use to participate in the fediverse.
Medical community on Mastodon

Administered by:

Server stats:

425
active users

med-mastodon.com: AboutProfiles directoryPrivacy policy

Mastodon: AboutGet the appKeyboard shortcutsView source codev4.3.7

#noCovid

1 post1 participant0 posts today
Public
Lars Marowsky-Brée 😷

It appears I'm finally part of the 1% 🥳

"with 99.4% (95% credible interval (CrI): 92.4-100%) having had at least one SARS-CoV-2 infection"

medrxiv.org/content/10.1101/20

medRxiv · National- and state-level SARS-CoV-2 immunity trends from January 2020 to December 2023: a mathematical modeling analysisIntroduction Effective immune protection against SARS-CoV-2 infection and severe COVID-19 disease continues to change due to viral evolution and waning immunity. We estimated population-level immunity to SARS-CoV-2 for each of the fifty United States (U.S.) and the District of Columbia from January 2020 through December 2023. Methods We updated a model of SARS-CoV-2 infections to align with the latest evidence on SARS-CoV-2 natural history and waning of immunity, and to integrate various data sources available throughout the pandemic. We used this model to produce population estimates of effective protection against SARS-CoV-2 infection and severe COVID-19 disease. Results On December 30, 2023, 99.9% of the U.S. population had experienced immunological exposure to SARS-CoV-2 through infection and/or vaccination, with 99.4% (95% credible interval (CrI): 92.4-100%) having had at least one SARS-CoV-2 infection. Despite this high exposure, the average population-level protection against infection was 53.6% (95% CrI: 38.7-71.5%). Population-level protection against severe disease was 82.6% (95% CrI: 71.5-91.7%). Discussion A new wave of SARS-CoV-2 infections and COVID-19-associated hospitalizations began near the end of 2023, with the introduction of the JN.1 variant. This upturn suggests that the U.S. population remains at risk of SARS-CoV-2 infection and severe COVID-19 disease despite the high level of cumulative exposure in the United States. This decline in effective protection is likely due to both waning and continued viral evolution. ### Competing Interest Statement The authors have declared no competing interest. ### Funding Statement This project has been funded (in part) by contract number 200-2016-91779 with the Centers for Disease Control and Prevention (CDC) and funding from the Centers for Disease Control and Prevention through the Council of State and Territorial Epidemiologists (Grant Number NU3OT000297). ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes All code and data used in this analysis are available on GitHub (https://github.com/covidestim). The produced datasets are available on the Harvard Dataverse (https://doi.org/ 0.7910/DVN/G2ZXJG). <https://github.com/covidestim> <https://doi.org/10.7910/DVN/G2ZXJG>
#LongCovid#Covid19#CovidIsNotOver
Public *
WERNERPRISE° — Thomas Werner

Hello Fediverse, hello Bits&Baeume,

I’ve moved recently, time for a (re)introduction — and a heartfelt Thank You! to @ben

I am a writer, copywriter, online editor, and I generally write a lot; I design websites with plain HTML/CSS/JS or using WordPress and other CMS; occasionally I work as a speaker, podcast producer, sound designer — to mention the most important bits.

My blog: wernerprise.com/blog (mostly German, but I am considering making it bilingual at some point.)

Climate catastrophe is on my mind, degrowth close to my heart; capitalism needs a short leash!

Also, I still take SARS-CoV-2 and COVID-19 very seriously. Thus:

#SARSCoV2 #COVID19 #COVID #NoCOVID #LongCOVID #COVIDIsNotOver #WearAMask #TeamCaution #CleanAir
#NewHere #Intro #ClimateCatastrophe #Capitalism #WealthRedistribution #TaxTheRich #Democracy #AntiAI #AntiFa #StopConsumerism #WeAreThe99Percent
#HTML #CSS #JavaScript #Webdesign #WordPress

wernerprise.comWERNERPRISE° — Das Blog. – Es gibt nicht immer was zu sagen.
Public
WERNERPRISE° — Thomas Werner

Hallo Fediverse, hallo Bits&Baeume,

ich bin umgezogen und erst seit ein paar Stunden hier auf dem neuen Server, deswegen eine kurze Vorstellung — und ein herzliches Dankeschön an @ben

Ich bin Texter und Online-Redakteur, schreibe auch sonst viel; ich gestalte Websites in HTML, mit WordPress oder anderen CMS, arbeite außerdem gelegentlich als Sprecher, Podcast-Produzent, Sounddesigner – um mal die wesentlichen Dinge genannt zu haben.

Mein Blog: wernerprise.com/blog

Mir liegt die Klimakatastrophe auf der Seele und Degrowth (Décroissance) am Herzen; Kapitalismus braucht straffe Zügel!

Außerdem nehme ich nach wie vor SARS-CoV-2 und COVID-19 ernst. Daher:

#SARSCoV2 #COVID19 #COVID #NoCOVID #LongCOVID #COVIDIstNichtVorbei #WearAMask #MaskeAuf #DieMaskeBleibtAuf #TeamVorsicht #CleanAir
#NeuHier #Intro #Klimawandel #KlimaKatastrophe #Kapitalismus #Umverteilung #Reichensteuer #Demokratie #AntiKI #AntiFa #Konsumstop #WirSindDie99Prozent
#HTML #CSS #JavaScript #Webdesign #WordPress

wernerprise.comWERNERPRISE° — Das Blog. – Es gibt nicht immer was zu sagen.
Public
Lorraine

" #WhatIf ..." - A Clinical Trial for #OCD - YouTube

youtube.com/watch?v=3ijVJ8c4_u

How about #WhatTheFuck !!!
This ad apparently ran on #CBS

I’m livid. When I actually use the f-💣 un-redacted, I’m fucking mad af #gaslighting

Firstly, I’m personally not cool enough to be #ocd or #adhd #etc & secondly this is incredibly dangerous precedent making #ZeroCovid #NoCovid as a psychological issue when it is an ACTUAL dangerous #airborneVirus

Ugh #iCant with this lame society

YouTube"What if..." - A Clinical Trial for OCDBy Biohaven
Public
Early Twix

Ok. Das Risiko bin ich eingegangen obwohl mir scheint von Freitagabend bis heute Nacht ist selbst für die schnellen Varianten etwas wenig. Ansonsten war ich eigentlich geschützt unterwegs. Leider habe ich damit Team #noCovid verlassen. Es war schön mit euch

Auf einer Holzoberfläche liegt ein positiver COVID Test
Continued thread
Public
Michael Kunz

Scheint also alles "gut" zu sein. Noch einen Schnaps vor meinem Dank an @mikrowie, @BrinkmannLab, @DirkBrockmann, @HallekMichael usw. für alles, gehen Sie weiter, hier gibt es nichts zu sehen, ich schreibe wieder, wenn wir 100% Berufsunfähigkeitsquote erreicht haben. #NoCovid /18

Continued thread
Public
Michael Kunz

2. Sie und die daraus abgeleitete "Durchseuchung" stand in diametralen Gegensatz zu einer Strategie einer weitgehenden Infektionsvermeidung und insbesondere der von @BrinkmannLab, @DirkBrockmann, @HallekMichael, @FuestClemens und anderen vertretenen Strategie von #NoCovid. /9

ExploreLive feeds
About